Hypertension Management Devices Market Revenue Status and Outlook 2019-2027 Made Available by Top Research Firm

Global Hypertension Management Devices Market: Overview

  • Hypertension is a key risk factor for cardiovascular diseases and continues to be a major cause of global morbidity and mortality. This is attributed to large number of patients with uncontrolled blood pressure, despite various pharmacological options available.

Read Report Overview – https://www.transparencymarketresearch.com/hypertension-management-devices-market.html

  • Novel technologies such as smartphones and Bluetooth-enabled tele-monitoring devices are playing key roles in hypertension management. The role of invasive management strategies for hypertension alongside medications is considered a possible treatment for hypertension patients.
  • The global hypertension management devices market is projected to grow at a significant pace during the forecast period, owing to rise in prevalence of resistant hypertension due to the inability to tolerate current pharmacological therapies

Key Drivers of Global Hypertension Management Devices Market

  • Resistant hypertension (RHTN) continues to contribute to the overall population’s cardiovascular morbidity and mortality. According to the American Journal of Hypertension, in 2015, the prevalence of resistant hypertension was reported to be between 14% and 16% of patients with hypertension globally. Hence, a number of patients prefer non-drug approach to resistant hypertension treatment. This factor is anticipated to boost the growth of the global hypertension management devices market.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76551

Restraints of Global Hypertension Management Devices Market

  • Not all types of hypertension management devices are reimbursed. A majority of health insurance plans in the U.S. do not cover hypertension management devices.
  • Insurance benefits for hypertension management devices vary from payer to payer. Some payers could cover monitors, but not additional support services provided by non-physicians.
  • Some private insurance plans in the U.S. provide benefits only to beneficiaries who are enrolled in the disease management programs for HTN or other medical conditions that have increased risk of developing heart diseases and causing stroke

Request for Custom Researchhttps://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76551

North America to Account for Major Share of Global Hypertension Management Devices Market

  • North America is likely to dominate the global hypertension management devices market during the forecast period due to rise in prevalence of hypertension as well as resistant hypertension, presence of major players, and increase in adoption of advanced devices to monitor hypertension. According to the CDC, in 2017, nearly half a million deaths in the U.S. included hypertension as a primary or contributing cause.
  • The hypertension management devices market in Asia Pacific is expected to expand at a high CAGR during the forecast period, owing to increase in the geriatric population with hypertension, rise in adoption of new treatment procedure to manage hypertension, surge in health care expenditure, and increase in awareness among people about preventive health care.

Pre Book Hypertension Management Devices Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=76551&ltype=S

Key Players Operating in Global Hypertension Management Devices Market

Major players operating in the global hypertension management devices market are:

  • Medtronic
  • Abbott
  • CVRx, Inc.
  • Boston Scientific Corporation
  • Mercator MedSystems
  • Ablative Solutions, Inc.
  • Kona Medical, Inc.
  • ReCor Medical, Inc.
  • PhysioCue
  • Others

More Trending Reports by Transparency Market Research –

Hereditary Angioedema Treatment Market: https://www.biospace.com/article/hereditary-angioedema-treatment-market-new-therapies-and-innovations-contributing-to-market-growth/

Hereditary Cancer Testing Market: https://www.biospace.com/article/hereditary-cancer-testing-market-north-america-to-account-for-major-share-of-global-market/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/